<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hedge Fund News From HedgeCo.Net &#187; food and drug</title>
	<atom:link href="http://www.hedgeco.net/news/tag/food-and-drug/feed" rel="self" type="application/rss+xml" />
	<link>http://www.hedgeco.net/news</link>
	<description>Breaking Hedge Fund News</description>
	<lastBuildDate>Fri, 10 Feb 2012 15:38:55 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>New FDA Chief Must Divest Several Stock, Fund Holdings</title>
		<link>http://www.hedgeco.net/news/05/2009/new-fda-chief-must-divest-several-stock-fund-holdings.html</link>
		<comments>http://www.hedgeco.net/news/05/2009/new-fda-chief-must-divest-several-stock-fund-holdings.html#comments</comments>
		<pubDate>Tue, 26 May 2009 00:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Syndicated]]></category>
		<category><![CDATA[10-million]]></category>
		<category><![CDATA[appointees]]></category>
		<category><![CDATA[company stocks]]></category>
		<category><![CDATA[disclosure forms]]></category>
		<category><![CDATA[financial disclosure]]></category>
		<category><![CDATA[fitzhugh]]></category>
		<category><![CDATA[food and drug]]></category>
		<category><![CDATA[food and drug administration]]></category>
		<category><![CDATA[fund holdings]]></category>
		<category><![CDATA[hamburg]]></category>
		<category><![CDATA[hedge fund]]></category>
		<category><![CDATA[husband peter]]></category>
		<category><![CDATA[lieutenant]]></category>
		<category><![CDATA[magnate]]></category>
		<category><![CDATA[mr brown]]></category>
		<category><![CDATA[new commissioner]]></category>
		<category><![CDATA[obama]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[wall-street-journal]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Wall Street Journal &#8211; The new commissioner of the Food and Drug Administration is among the wealthiest Obama administration appointees, with income of at least $10 million in 2008 thanks mostly to her husband, a hedge-fund executive, according to financial disclosure forms. Margaret Hamburg and her husband, Peter Fitzhugh Brown, must divest themselves of several [...]]]></description>
		<wfw:commentRss>http://www.hedgeco.net/news/05/2009/new-fda-chief-must-divest-several-stock-fund-holdings.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indevus soars on drug, hedge fund news</title>
		<link>http://www.hedgeco.net/news/03/2009/indevus-soars-on-drug-hedge-fund-news.html</link>
		<comments>http://www.hedgeco.net/news/03/2009/indevus-soars-on-drug-hedge-fund-news.html#comments</comments>
		<pubDate>Tue, 03 Mar 2009 00:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Syndicated]]></category>
		<category><![CDATA[bladder cancer]]></category>
		<category><![CDATA[boston business journal]]></category>
		<category><![CDATA[cancer therapy]]></category>
		<category><![CDATA[common stock]]></category>
		<category><![CDATA[drug application]]></category>
		<category><![CDATA[early monday]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[food and drug]]></category>
		<category><![CDATA[food and drug administration]]></category>
		<category><![CDATA[indevus pharmaceuticals inc]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[north carolina]]></category>
		<category><![CDATA[regulatory approval]]></category>
		<category><![CDATA[regulatory filings]]></category>
		<category><![CDATA[second half]]></category>
		<category><![CDATA[securities-and-exchange]]></category>
		<category><![CDATA[securities-and-exchange-commission]]></category>
		<category><![CDATA[valstar]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Boston Business Journal &#8211; Just days after winning regulatory approval for the manufacture and marketing of its cancer therapy for bladder cancer, Indevus Pharmaceuticals Inc. disclosed that a North Carolina hedge fund has acquired 8.5 percent of its common stock. Lexington, Mass.-based Indevus made the announcements via regulatory filings late Friday and early Monday with [...]]]></description>
		<wfw:commentRss>http://www.hedgeco.net/news/03/2009/indevus-soars-on-drug-hedge-fund-news.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using disk: enhanced
Database Caching 1/13 queries in 0.457 seconds using disk: basic
Object Caching 269/318 objects using disk: basic

Served from: www.hedgeco.net @ 2012-02-13 08:48:09 -->
